Bausch Health
BHC
#3604
Rank
ยฃ2.28 B
Marketcap
ยฃ6.23
Share price
2.00%
Change (1 day)
0.25%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

Bausch Health (BHC) - Total debt

Total debt on the balance sheet as of June 2024 : ยฃ16.50 B

According to Bausch Health 's latest financial reports the company's total debt is ยฃ16.50 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Bausch Health - Total debt on balance sheet (from 1996 to 2023)

Total debt by year

Year Total debt Change
2023-12-31ยฃ17.57 B2.38%
2022-12-31ยฃ17.16 B2.54%
2021-12-31ยฃ16.73 B-4.49%
2020-12-31ยฃ17.52 B-10.19%
2019-12-31ยฃ19.51 B2.44%
2018-12-31ยฃ19.04 B1.18%
2017-12-31ยฃ18.82 B-22.17%
2016-12-31ยฃ24.18 B15.36%
2015-12-31ยฃ20.96 B114.24%
2014-12-31ยฃ9.78 B-7%
2013-12-31ยฃ10.52 B54.34%
2012-12-31ยฃ6.81 B59.35%
2011-12-31ยฃ4.27 B78.35%
2010-12-31ยฃ2.39 B881.79%
2009-12-31ยฃ0.24 B453.18%
2008-12-31ยฃ44.17 M
2006-12-31ยฃ0.20 B-17.27%
2005-12-31ยฃ0.25 B1.46%
2004-12-31ยฃ0.24 B-45.5%
2003-12-31ยฃ0.45 B-1.7%
2002-12-31ยฃ0.46 B1364.01%
2001-12-31ยฃ31.83 M-93.57%
2000-12-31ยฃ0.49 B481.63%
1999-12-31ยฃ85.09 M11.51%
1998-12-31ยฃ76.31 M2458.49%
1997-12-31ยฃ2.98 M-27.03%
1996-12-31ยฃ4.08 M

Total debt for similar companies or competitors

Company Total debt differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.20 B-98.76%๐Ÿ‡บ๐Ÿ‡ธ USA